![Megan Baldwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Megan Baldwin
Directeur/Membre du Conseil chez
RACURA ONCOLOGY LTD
Fortune : 73 671 $ au 31/03/2025
Profil
Megan Baldwin was the founder of Opthea Ltd., founded in 1984, and served as Chief Innovation Officer from 2024 to 2025.
Current jobs include Deputy Chairman at AusBiotech Ltd. since 2017, Director at Anaxis Pharma Pty Ltd., Director at Gertrude Biomedical Pty Ltd., Independent Non-Executive Director at Racura Oncology Ltd. starting in 2025, and Member at the Australian Institute of Co. Directors.
Former jobs include Chief Executive Officer at Opthea Pty Ltd. from 2012 to 2015, Independent Non-Executive Director at Invex Therapeutics Ltd. from 2021 to 2024, and Member at Roche Group Pty Ltd. Education includes a doctorate from the University of Melbourne.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OPTHEA LIMITED 0,02 % | 05/09/2025 | 195 299 ( 0,02 % ) | 73 671 $ | 31/03/2025 |
RACURA ONCOLOGY LTD -.--% | 25/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Megan Baldwin
| Sociétés | Poste | Début |
|---|---|---|
| RACURA ONCOLOGY LTD | Directeur/Membre du Conseil | 01/01/2025 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Directeur/Membre du Conseil | 14/12/2017 |
Anaxis Pharma Pty Ltd.
 Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Directeur/Membre du Conseil | - |
Anciens postes connus de Megan Baldwin
| Sociétés | Poste | Fin |
|---|---|---|
| OPTHEA LIMITED | Directeur Général | 27/10/2023 |
| INVEX THERAPEUTICS LTD | Directeur/Membre du Conseil | 30/06/2024 |
Opthea Pty Ltd. | Directeur Général | 01/12/2015 |
Roche Group Pty Ltd. | Corporate Officer/Principal | - |
Formation de Megan Baldwin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Roche Group Pty Ltd. | |
Opthea Pty Ltd. | |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Invex Therapeutics Ltd.
 Invex Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company and develops therapeutics for neurological conditions | Health Technology |
Anaxis Pharma Pty Ltd.
Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Health Technology |
